
|Articles|April 12, 2019
Glaucoma 360 founders discuss innovation at 2019 meeting
Drs. Graves and Iwach, co-founders of the Glaucoma 360 meeting, discuss the biggest advances in innovation and research at the 23rd annual meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.
Advertisement
Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, co-founders of the Glaucoma 360 meeting, discuss the biggest advances in innovation and research at the 23rd annual meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
2
Remigromig noninferior to ranibizumab in phase 2b/3 BRUNELLO DME trial
3
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
4
Retina Society 2026: Ocular syphilis, HIV co-infection, and RPR titers
5











